People's daily steps might drop after starting a GLP-1 prescription, new research suggests.
The Department of Justice has no issue with Paramount getting what it wants, but state AGs and overseas regulators still have concerns.
At least not legally.
An AI startup founder is using Claude to make a GTA ripoff.